Ajinomoto Co., Inc.
Ajinomoto Co., Inc. (AJINY) Financial Performance & Income Statement Overview
Analyze Ajinomoto Co., Inc. (AJINY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Ajinomoto Co., Inc. (AJINY) Income Statement & Financial Overview
Analyze Ajinomoto Co., Inc.’s AJINY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $379.52B | $406.79B | $378.74B | $365.51B |
| Cost of Revenue | $250.75B | $256.15B | $240.79B | $232.11B |
| Gross Profit | $128.78B | $150.64B | $137.95B | $133.40B |
| Gross Profit Ratio | $0.34 | $0.37 | $0.36 | $0.36 |
| R&D Expenses | $9.13B | $7.05B | $7.20B | $7.54B |
| SG&A Expenses | $98.91B | $94.23B | $88.61B | $85.11B |
| Operating Expenses | $108.04B | $100.56B | $95.86B | $92.59B |
| Total Costs & Expenses | $358.78B | $356.71B | $336.65B | $324.70B |
| Interest Income | $2.11B | $2.08B | $2.04B | $2.56B |
| Interest Expense | $4.39B | $290.00M | $3.75B | $3.54B |
| Depreciation & Amortization | $22.27B | $21.57B | $21.19B | $21.44B |
| EBITDA | $7.04B | $71.60B | $59.56B | $59.93B |
| EBITDA Ratio | $0.02 | $0.18 | $0.16 | $0.16 |
| Operating Income | $20.74B | $50.07B | $42.09B | $40.80B |
| Operating Income Ratio | $0.05 | $0.12 | $0.11 | $0.11 |
| Other Income/Expenses (Net) | -$40.36B | -$2.60B | -$3.74B | -$3.30B |
| Income Before Tax | -$19.63B | $47.47B | $38.35B | $37.51B |
| Income Before Tax Ratio | -$0.05 | $0.12 | $0.10 | $0.10 |
| Income Tax Expense | -$8.94B | $14.18B | $9.27B | $13.05B |
| Net Income | -$12.17B | $32.21B | $26.26B | $23.97B |
| Net Income Ratio | -$0.03 | $0.08 | $0.07 | $0.07 |
| EPS | -$93.31 | $64.26 | $51.98 | $46.98 |
| Diluted EPS | -$93.31 | $64.26 | $51.98 | $46.98 |
| Weighted Avg Shares Outstanding | $1.007B | $501.28M | $505.15M | $510.15M |
| Weighted Avg Shares Outstanding (Diluted) | $1.007B | $501.28M | $505.15M | $510.15M |
Financial performance has remained strong, with revenue growing from $365.51B in Q1 2024 to $379.52B in Q4 2024. Gross profit continued to perform well, with margins at 34% in the latest quarter. Operating income reached $20.74B in Q4 2024, holding a steady 5% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $7.04B. Net income dropped to -$12.17B, keeping EPS at -$93.31. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan